NP525312.RAxxS XUw9z1l-ndMMFqodhUyewRGXQQj--rMQT-NQR6U
has assertion: NP525312.RAxxS XUw9z1l-ndMMFqodhUyewRGXQQj--rMQT-NQR6U130 assertion
has provenance: NP525312.RAxxS XUw9z1l-ndMMFqodhUyewRGXQQj--rMQT-NQR6U130 provenance
has publication info: NP525312.RAxxS XUw9z1l-ndMMFqodhUyewRGXQQj--rMQT-NQR6U130 publicationInfo
type: Nanopublication
created: 2015-08-25T14:42:50+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v3.0.0.0

NP525312.RAxxS XUw9z1l-ndMMFqodhUyewRGXQQj--rMQT-NQR6U130 assertion
type: Assertion
description: [Our results provide evidence that the mechanisms of Sp1/NFkappaB/HDAC/miR-29b-dependent KIT overexpression contribute to leukemia growth and can be successfully targeted by pharmacological disruption of the Sp1/NFkappaB/HDAC complex or synthetic miR-29b treatment in KIT-driven AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/20385359
was generated by: ECO_0000203

befree-20150227
imported on: 2015-02-27

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v3.0.0